Live
0Stores tracked

Choose your display currencywe'll convert every price on the platform for you (daily FX rates, shown as estimates).

Public product signal preview

Review the observed product, store and freshness evidence below. Create a free account for monthly reveals, or subscribe for full proof panels, cross-store comparisons and research depth.

Store catalogue last scanned 11 days ago

C+ Correcting Complex 30%® 1 fl oz
View live product pageAliExpressFind on AliExpress

C+ Correcting Complex 30%® 1 fl oz

Confirmed winnerBest-seller #10
$185.00in stock
Description

C+ Correcting Complex 30%® - Reveal a brilliant glow, a more even skin tone and a more youthful appearance. Infused with our patent-pending MelaPATH® technology that illuminates, refines, and rejuvenates, C+ Correcting Complex 30%® defends and corrects the skin-damaging effects of free radicals generated by Urban Dust and High Energy Visible light (HEV or blue light). Helps to support the skin’s natural production of Vitamins C and E Delivers the next generation of Vitamin C - correcting existi…

revisionskincareskincare
Best-seller rank
#10
in this store
Sustained advertising
22 months running
from ad observations
VendorrevisionskincareTypeSkincarePublishedFeb 17, 2026CurrencyUS$ USDFirst seenJul 5, 2026Last seenJul 5, 2026Last crawledJul 5, 2026

Cross-store presence

LoadingLoading
Traffic 250K–500KSales $955K – $2MProducts 108ShopifyShopify
View full store intelligence

More products from this store

LoadingLoading

GoogleGoogle Ads transparency

AdvertiserCountryFormatVerifiedFirst shownLast shown
NakedMDtextVerified24 Feb 2026, 17:39:07 UTC5 Jul 2026, 19:25:07 UTC
NakedMDtextVerified24 Feb 2026, 05:40:03 UTC5 Jul 2026, 08:05:12 UTC
NakedMDtextVerified27 Feb 2026, 22:55:05 UTC6 Jul 2026, 01:48:53 UTC
NakedMDtextVerified17 Mar 2026, 08:59:30 UTC5 Jul 2026, 20:02:33 UTC
NakedMDtextVerified17 Mar 2026, 08:05:50 UTC5 Jul 2026, 12:18:29 UTC

All figures are estimated and signal-based — never exact sales or ad spend. Cross-store matches are title-based estimates.